De-escalation in intensity or duration of dual antiplatelet therapy in patients with coronary artery disease: More than alternative treatment options

Eur J Intern Med. 2023 Apr:110:16-18. doi: 10.1016/j.ejim.2023.02.006. Epub 2023 Feb 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Aspirin / therapeutic use
  • Coronary Artery Disease* / drug therapy
  • Drug Therapy, Combination
  • Hemorrhage / chemically induced
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin